Stay updated on Atezolizumab in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in Advanced NSCLC Clinical Trial page.

Latest updates to the Atezolizumab in Advanced NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe clinical trial record for atezolizumab in advanced non-small cell lung cancer is displayed, including study details, eligibility criteria, treatment and outcome measures, and record history.SummaryDifference56%

- Check22 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check29 days agoChange DetectedA site-wide NIH announcement banner appears above the ClinicalTrials.gov 403 error page, describing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check36 days agoChange DetectedThe revision number in the footer of the 403 error page changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check43 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1; the study page remains a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Atezolizumab in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Advanced NSCLC Clinical Trial page.